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Abstract 
The exploration of stem and progenitor cells holds promise for advancing our understanding of the biology 
of tissue repair and regeneration mechanisms after injury. This will also help in the future use of stem cell 
therapy for the development of regenerative medicine approaches for the treatment of different tissue-specie 
defects or disorders such as bone, cartilages and tooth defects or disorders. Bone is a specialized connective 
tissue, with mineralized extracellular components that provide bones with both strength and rigidity, and thus 
enable bones to function in body mechanical supports and necessary locomotion process. New insights have 
been added to the use of different types of stem cells in bone and tooth defects over the last few years. In this 
concise review, we briefly describe bone structure as well as summarize recent research progress and 
accumulated information regarding the osteogenic differentiation of stem cells, as well as stem cell 
contributions to bone repair/regeneration, bone defects or disorders and both restoration and regeneration of 
bones and cartilages. We also discuss advances in the osteogenic differentiation and bone regeneration of 
dental and periodontal stem cells as well as in stem cell contributions to dentine regeneration and tooth 
engineering. This article is protected by copyright. All rights reserved 
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Introduction  
Stem cells can continuously produce unaltered daughters and could generate cells with different and more 
restricted properties. Stem cells can divide either symmetrically (allowing the increase of stem cell number) 
or asymmetrically. Asymmetric divisions keep the number of stem cells unaltered and are responsible for the 
generation of cells with different properties. These cells can either multiply (progenitors or transit amplifying 
cells) or be committed to terminal differentiation (Morrison and Kimble, 2006; Berika et al., 2014; 
Elshahawy et al., 2016; El-Hashash, 2015).  
 
Progenitors and transit amplifying cells have a limited lifespan and therefore can only reconstitute a tissue 
for a short period of time when transplanted. In contrast, stem cells are self-renewing and thus can generate 
any tissue for a lifetime. This is a key property for a successful therapy. The capacity to expand stem cells in 
culture is an indispensable step for regenerative medicine, and a considerable effort has been made to 
evaluate the consequences of the cultivation on stem cell behavior. Scientists rely on indirect properties to 
identify stem cells such as the expression of a repertoire of surface proteins, slow cell cycle, clonogenicity, 
or an undifferentiated state. The evaluation of self-renewal is the ultimate way to show “stemness”, which 
relies on the isolation and transplantation of a putative stem cell (clonal analysis) followed by its serial 
transplantation and long-term reconstitution of a tissue (He et al., 2009). 
Recently, stem cells have been used extensively in many medical disciplines for the repair and/ or 
regeneration of defective tissues and organs (e.g. bone, ligament, heart). New therapeutic approaches are 
largely inspired and based on our knowledge of embryonic development. The goal of regenerative medicine 
is to stepwise re-create in vitro all the mechanisms and processes that nature uses during initiation and 
morphogenesis of a given organ. In this context, stem cell research offers an amazing and seductive potential 
for body homeostasis, repair, regeneration and pathology. The possibility of manipulating stem cells in situ 
using specific signalling molecules or by expanding them ex vivo is an exciting outcome of basic research. 
Hence, regenerative medicine has become a fashionable field and the isolation and manipulation of 
embryonic and adult (or post-natal) stem cells for the creation of new functional organs that will replace the 
missing or defective organs constitutes an enormous challenge. Adult stem cells (ASC), which possess a 
restricted potential of differentiation, can easily be isolated from a patient and after in vitro amplification 
This article is protected by copyright. All rights reserved  4 
and/or differentiation could be re-injected to the same patient thus avoiding immune rejection, as is the case 
for allografts or xenografts. However, the knowledge in stem cell technology is increasing quickly in all 
medical disciplines and dictates the need for new strategic approaches in all fields, including reparative 
dentistry. Stem cells have a great hope for various tissue repair, regeneration and engineering as well as for 
treatments of different human diseases (Mimeault and Batra, 2006; Caplan, 2007). 
Structure of the bone 
The bone is a rigid organ that support and protect the various organs of the body, produces red and white 
blood cells, store minerals and enable mobility as well as support for the body. Bone is a specialized type of 
dense connective tissue as its extracellular components is mineralized to provide strength and rigidity. This 
makes it capable to fulfil its major role in supporting the whole body mechanically and in locomotion 
(Weatherholt et al., 2012). It gives attachment to skeletal muscles, protects organs and plays a significant 
role in mineral homeostasis, particularly calcium and phosphorus (de Baat et al., 2005; Bayliss et al., 2012). 
 
Osteon is regarded as the building unit of a bone. It consists of concentric lamellae around a Haversian canal. 
Osteons are connected to each other and to the periosteum by oblique channels called volkmann’s canals. 
The space between osteons is occupied by interstitial lamellae which are remnants of osteons that were 
partially resorbed during the process of bone remodelling (Bayliss et al., 2012). 
 
There are two types of osseous tissue; the solid cortical compact bone tissue and the cancellous bone or 
spongy bone. The solid cortical compact bone tissue is the hard-outer layer of the bone. It is one of the two 
types of osseous tissue that form bones. It forms 80% of osseous mass; provide levers for movements and 
store and release chemical elements mainly calcium (Marieb, 1998). The cancellous bone, also known as 
trabecular or spongy bone, is found at the ends of long bones, as well as in the pelvic bones, ribs, skull, and 
the vertebrae. It has many pores covering 50-90 % of its volume. These pores give it spongy honeycomb-like 
appearance. Cancellous bone is highly vascular and frequently contains red bone marrow where 
haematopoiesis occurs (Marieb, 1998; Weatherholt et al., 2012; Gdyczynski, 2014). 
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The periosteum that lines surfaces of bone is divided into two layers; an outer fibrous layer and an inner 
cambium or osteogenic layer. The fibrous layer contains fibroblasts while the cambium layer is in contact 
with the bone. It contains the progenitor cells, which develop into osteoblasts (Weatherholt et al., 2012).  
 
Matrix of the bone 
It is the intercellular substance of bone tissue. It consists of collagen fibres, ground substance and inorganic 
bone salts. Type I collagen provides bone with its flexibility and is the main component of its organic 
portion. The remainder is made up of osteoids, proteoglycans and non-collagenous proteins including 
fibronectin, osteocalcin, osteonectin, thrombospondin and matrix-gla-protein. Fibronectin is abundant and 
regulates osteoblast differentiation while osteonectin regulates mineralization. Thrombospondin inhibits 
bone cell precursors while osteocalcin binds calcium. Lastly, matrix-gla-protein prevents mineralization. On 
the other hand, the inorganic portion of the bone matrix acts as an ion reservoir (Weatherholt et al., 2012).  
 
The matrix is mostly made up of a composite material incorporating the inorganic minerals including 
calcium phosphate in the chemical arrangement termed calcium hydroxylapatite [Ca10 (PO4)6 (OH)2], 
which is the bone mineral that gives bones their rigidity, fluoride, sodium, potassium, and magnesium in 
addition to collagen which is an elastic protein that improves its fracture resistance. Bone stiffness and 
flexibility are provided by its collagen and minerals (Weatherholt et al., 2012; Bayliss et al., 2014). 
 
Cellular elements of the bone 
The major cell types of bone are osteoblasts (OBs), osteoclasts (OCs), and osteocytes (Kartsogiannis, 2004). 
The haematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) give rise to the osteoclasts that 
modulate bone resorption and osteoblasts that mediate bone formation. Osteoblasts are necessary for bone 
reconstruction (Weatherholt et al., 2012). The human skeleton integrity and strength are dependent on a 
delicate balance between bone formation by osteoblasts and bone resorption by osteoclasts. This balance is 
affected by various types of genetic and mechanical alterations. Degenerative skeletal diseases, including 
osteoporosis, become increasingly prevalent during human life. Osteoporosis, for example, reflects a relative 
preponderance of osteoclast activity and bone resorption exceeds bone formation (Weatherholt et al., 2012).  
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MSCs are defined as self-renewing and multipotent cells capable of differentiating into multiple cell types 
including osteocytes and chondrocytes. MSCs were originally isolated from the bone marrow stroma but 
they have recently been identified also in other tissues such as fat, epidermis and cord blood. It remains in a 
non-proliferative, quiescent state until stimulated by the signals triggered by tissue renewal, damage and 
remodelling process. Development of MSCs is associated with mesodermal sclerotome condensation that 
subsequently differentiates into other cell types for bone remodelling. Stimulatory factors are needed for 
MSCs. They are derived from osteoblastogenesis such as the bone morphogenetic protein (BMPs), which act 
as the starting inducer of osteoblastogenesis. Seven BMPs were discovered. Of these, six belong to the 
Transforming growth factor beta superfamily of proteins (TGFβ). MSCs which are derived from bone 
marrow fat plays a major role in accelerating bone fracture tackling as they are the precursors of osteoblasts 
(Quarto et al., 2001). Bone marrow contains both hematopoietic stem cells and MSCs. Bone marrow 
transplantation has been advocated as a potential future therapeutic modality for osteogenesis imperfecta 
(Horwitz et al., 2002). 
 
 
 
Remodeling of the bone 
It is a lifelong skeletal dynamic process which occurs over several weeks and is performed by clusters of 
bone-resorbing osteoclasts and bone-forming osteoblasts arranged within the temporary anatomical 
structures known as the Basic Multicellular Units (BMU), which consist of osteoclasts, osteoblasts, and 
osteocytes (Kular et al., 2012). In the BMU, the amount of bone destroyed by osteoclasts is equal to the 
amount of bone formed by osteoblasts (Lips et al., 1978). Mature bone tissue is removed from the skeleton (a 
process called bone resorption) and new bone tissue is formed (a process called ossification). These 
processes control the reshaping or replacement of bone following fractures and micro-damage which occurs 
during normal activity. An imbalance in the regulation of bone remodeling’s two sub-processes, bone 
resorption and bone formation, results in many metabolic bone diseases such as osteoporosis (Raggatt et al., 
2010). Moreover, bone remodelling is a life-dominant process, where cortical and trabecular bone is rebuilt, 
and it plays a crucial role in bone mass balance and mineral homeostasis (Tolar et al., 2004). Intriguingly, 
This article is protected by copyright. All rights reserved  7 
non-BMU cells, including T-cells, B-cells, and nerve cells also play an important role in bone remodelling 
(Gillespie et al., 2007; Horowitz and Lorenzo, 2007; Elefteriou, 2008). 
 
The remodelling mechanism of the bone includes initiation phase, reversal phase and termination phase. 
Initiation phase is the first process in the remodelling cycle, in which osteoclast precursors are recruited and 
differentiated into mature osteoclasts to maintain bone resorption. Reversal phase is associated with bone 
resorption inhibition and the osteoblasts are recruited and started to be differentiated.  Termination phase is 
the final step in the cycle which occurs when an equal quantity of resorbed bone has been replaced, the 
remodelling cycle concludes (Kular et al., 2012, Raggatt and Partridge, 2010). Finally, there is a connected 
network among each of those cells and the osteocytes (Kular et al., 2012). This phase is based on a 
mechanism that requires a key mediator called receptor activator of nuclear factor kappa-B ligand (RANKL), 
which is essentially required for osteoclastogenesis (Dougall et al., 1999; Palmqvist et al., 2002). Ligand-
receptor interaction of RANKL-RANK triggers the termination phase by promoting osteoclast precursor 
fusion and colony stimulating factor (CSF-1) (Arai et al., 1999; Parfitt et al., 2002; Lee et al., 2006; Tatsumi 
et al., 2007). The BMU that comprises the remodelling process in the bone involves multiple Intercellular 
communication pathways, as summarized in Figure (1).  
 
Much of bone turnover markers, that quantify bone resorption, are collagen breakdown products, 
telopeptides, and pyridinoline rings (Brown et al., 2009). Deoxypyridinoline (DPD) is released into the 
circulation after resorption of bone matrix and thereafter is excreted in urine (Garnero and Delmas, 2004). 
BMU at the initiation, reversal (transition) and termination phases of bone remodelling cycle. 
 
Osteogenic differentiation of stem cells  
Identification and isolation of osteoprogenitor cells and other stem cell types that are capable of 
osteochondral differentiation to inform both bone repair and regeneration is a subject of several recent 
studies. For instance, human adipose tissue-derived mesenchymal stem cells (hAMSCs) are capable to both 
differentiate into osteoblasts and produce bone matrix of bone marrow derived stem cells (Tognarini et al., 
2008). Moreover, Olivares-Navarrete et al. (2010) have shown that human mesenchymal stem cells (MSCs) 
can differentiate into osteoblasts when growing on Titanium surfaces with microscale roughness even if the 
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culture medium lacks osteogenic components. It has also been shown that nanostructured Titanium alloys 
(Ti6Al4V and Ti13Nb13Zr) can sustain the proliferation, growth and adhesion of hAMSCs. These alloys 
also promote the osteogenic differentiation of hAMSCs (Marini et al., 2015). In addition, a recent study by 
Gothard and co-workers has shown that regionally-derived cell populations and skeletal stem cells from 
human fetal femora exhibit specific osteochondral and multi-lineage differentiation capacity both ex vivo 
and in culture (Gothard et al., 2015). 
 
Several factors have been reported to regulate stem cell function and differentiation into osteoblasts. For 
instance, Hox transcription factors regulate skeletal patterning during embryogenesis, and are expressed in 
adult bone tissues. They are expressed in specific and restricted domains and control the morphology of 
certain vertebral and long bone elements (Rux and Wellik , 2017). Progenitor-enriched populations of 
mesenchymal stem/ stromal cells (MSCs) express Hox genes in the adult skeleton, in which these genes play 
an important role in both skeletal regeneration and the fracture healing process (reviewed by Rux 
and Wellik , 2017). 
 
Most recently, members of zinc-finger transcription factors, Snail and Slug, have been reported to regulate 
both the behavior and function of bone marrow-derived mesenchymal stem cells (MSCs) as well as 
bone formation (Tang and Weiss, 2017). Snail and Slug are zinc-finger transcription factors are well-known 
regulators of the epithelial-mesenchymal transition (EMT) programs during both normal development and 
disease progression. Tang and Weiss (2017) have recently reported that both Snail/Slug and the two co-
transcriptional effectors of the Hippo pathway, YAP/TAZ, cooperatively interact. This interaction is 
important for the control of self-renewal and differentiation properties of bone marrow-derived 
mesenchymal stem cells, which is a critical cell population in both bone development and morphogenesis 
(Tang and Weiss, 2017). 
 
Growth factors and extracellular matrix proteins also play important roles in the osteogenic differentiation of 
stem cells. For instance, a recent research by Wang  Y
 
et al. (2016) has investigated the positive and 
reciprocal effect of TGF-β3 on BMP-2 growth factor in promoting osteogenic differentiation, based on an 
early study by (Haschtmann et al., 2012) that showed that co-delivery of  BMP-2 and TGF-β3 is more 
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effective than single gene-transfection in promoting ossification of the annulus fibrosus. Wang  and co-
workers simultaneously expressed BMP-2 and TGF-β3 genes in rabbit bone marrow-derived mesenchymal 
stem cells. Then, they measured the expression status of both BMP-2 and TGF-β3 in culture to elucidate 
whether these growth factors can be synergistically expressed in vivo. This study has demonstrated a 
synergistic effect of the overexpression of BMP-2 and TGF-β3 on osteogenic differentiation of bone marrow 
mesenchymal stem cells Wang 
 
et al. (2016). In addition, Polini et al. (2014) have developed a strategy, 
based on in situ delivery of growth factor-inspired peptides through their immobilization onto 
Hydroxyapatite (HA), which is the principal component of bone mineral, surfaces. This study found that 
stable biofunctionalization of HA surfaces by HA-binding/osteogenic modular peptides induces osteogenic 
differentiation of mesenchymal stem cells (Polini et al., 2014). 
 
Stem cell contributions to bone repair and regeneration 
Several reports have shown that mesenchymal stem cells (MSC) that are derived from periosteum and bone 
marrow are involved in fracture repair. They have also shown that the impairment of bone regeneration is 
probably due to a damage of the surrounding skeletal muscle (reviewed in Owston et al., 2016). For example, 
a recent study from Cao’s laboratory (Islam et al., 2016) has shown that fluorescently labelled human 
embryonic stem cells-derived osteoprogenitors (hESC-OPs) are able to maintain both their GFP expression 
for the long term and their potential for osteogenic differentiation in culture. This will help in the future 
application of these fluorescently labelled hESC-OPs in the noninvasive assessment of bone regeneration and 
therapeutic efficacy.  
 
Bone marrow stem cells can grow in vitro, and cultured bone marrow osteoprogenitors can be used for bone 
regeneration after seeding on an appropriate scaffold material, as shown in Figure (2). Most recently, Chen et 
al. (2017) have shown evidences of a successful angiogenic and osteogenic regeneration in rats via calcium 
phosphate scaffold (CPC) and endothelial cell co-culture with human bone marrow MSCs (hBMSCs), 
human umbilical cord MSCs (hUCMSCs), induced pluripotent stem cells (hiPSC-MSCs) and 
embryonic stem cells (hESC-MSCs). Thus, co-cultures of hUVECs with hUCMSCs, hiPSC-MSCs, hESC-
MSCs and hBMSCs delivered via CPC scaffold have achieved excellent osteogenic and angiogenic 
capabilities in vivo (Chen et al., 2017). These co-culture constructs will provide promising solutions for bone 
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reconstruction with improved angiogenesis for both orthopedic and craniofacial applications. Similarly, a 
recent study has shown a successful bone regeneration in minipigs via calcium phosphate cement scaffold 
delivering autologous bone marrow mesenchymal stem cells (BMSCs) and autologous platelet-rich plasma 
(Qiu et al., 2017). Another approach that has also been reported to be successful for prompting bone 
regeneration is the incorporation of a bone marrow-derived mesenchymal stem cell (BMSC) sheet into the 
platelet-rich plasma (PRP) gel/calcium phosphate particles, which will offer effective therapeutic strategies 
for promoting the clinical repair of bone defects (Qi et al., 2015).  
 
Furthermore, a most recent research by Joo et al. has compared bone regeneration using allogeneic 
cancellous bone granule scaffolds loaded with autologous bone marrow-derived mesenchymal stem 
cells (BM-MSC) with or without autologous platelet-rich plasma (PRP), and showed a similar progression 
of new bone formation and maturation (Joo et al., 2017). Furthermore, several recent reports have 
highlighted the advantages of adipose-derived stem cells (ASCs) over other stem cells that are derived 
from bone marrow. These advantages include a higher number of stem cell progenitors from an equivalent 
amount of tissue harvested, a less invasive procedure of cell harvesting, a significate increase of both 
proliferation and differentiation capacities, as well as better osteogenic/angiogenic properties in vivo 
(Dufrane, 2017). 
 
Stem cell contributions to bone defects and both restoration and regeneration of bones and cartilages 
 
The cranial and facial bone defects are complicated, particularly because of the difficulty of finding an 
appropriate autologous bone transplant for them. Current treatments of these defects using stem cells have 
been successful, and their safety have been proved using preclinical experiments. For instance, several 
reports have shown the effective functions of   adipose-derived stem cells in the experimental treatment 
of different types of bone defects (reviewed by Seppänen and Miettinen, 2014).  
  
Bone marrow-derived mesenchymal stem cells (BMSC) are also important cell population for bone tissue 
repair, engineering and regeneration. Addition of recombinant human bone morphogenetic protein (rhBMP-
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2) to a silica-coated calcium hydroxyapatite (HASi)- rabbit BMSC (rBMSC) construct could 
promote bone healing and regeneration in a large critical-size-defect in rabbits (Maiti et al., 2016). 
Umbilical cord mesenchymal stem cells (UCMSCs) and amniotic fluid-derived stem cells (AFSCs) are also 
attractive cell populations for bone repair/regeneration as well as promising candidates for cell therapy and 
tissue engineering. In a recent study from Liu’s laboratory, UCMSCs were transplanted into the bone defect 
peri-implant, and were capable to promote bone repair/regeneration and new bone formation (Hao et al., 
2014). In contrast, both the experimental and preclinical applications of AFSCs in bone repair/regeneration, 
including maxillofacial bone tissue engineering, are still limited. However, a recent study by  Wang and 
others (Wang et al., 2017) has proposed an AFSCs-based bone tissue engineering strategy for congenital 
alveolar cleft restoration. This study has evaluated the regenerative properties of AFSCs in restoration of 
alveolar bone defect, and provided evidences of the feasibility of an AFSCs-based alveolar bone tissue 
engineering strategy for alveolar defect restoration (Wang et al., 2017). 
 
Similarly, stem cells are a highly promising tool for new developments in cartilage tissue regeneration.  Both 
ex vivo expanded chondrocytes and BMSC are currently extensively used in the regeneration of damaged 
cartilages. BMSC are the most used stem cell source in the engineering and repair of cartilage tissues 
(Georgi et al., 2014; Tritz-Schiavi et al., 2010). However, the use of autologous BMSC have certain limits, 
including possible damage of donor site, painful collection methods, low number of available BMSC, and 
the decrease of both their proliferation capacity and differentiation potential with age (Pittenger et al., 1999; 
Zaim et al., 2012; Fossett et al., 2012). To help with sorting out these difficulties, Reppel and his colleagues 
have attempted to identify alternative sources of MSC in cartilage tissue repair/engineering (Reppel et al., 
2015). They have evaluated the chondrogenic potential of mesenchymal stromal/stem cells from Wharton’s 
jelly (WJ-MSC), which were embedded in alginate/hyaluronic acid (Alg/HA) hydrogel, compared to the 
potential of BMSC. This study has found that WJ-MSC, embedded in a three-dimensional environment, were 
able to adapt to their environment and express specific cartilage-related genes and matrix proteins and, 
therefore, represent a promising alternative stem cell source for cartilage tissue engineering (Reppel et al., 
2015). Another new replacement cell source for cartilage repair is human induced pluripotent stem 
cells (hiPSCs), mostly because of their multipotency and unlimited self-renewal ability. Nam and others 
(2017) have mostly recently reported the characteristics of cartilage-like chondrogenic pellets generated from 
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cord blood mononuclear cell-derived hiPSCs (CBMC-hiPSCs), suggesting these cells as a potential cell 
source for cartilage repair and regeneration. 
 
Osteogenic differentiation and bone regeneration of dental and periodontal stem cells  
Human periodontal ligament (PDL) represents a unique reservoir of stem cells because it contains a unique 
population of multipotent stem cells, which have the capacity to differentiate and form cells with diverse 
phenotypes (Mrozik et al., 2010). Moreover, Seo et al. (2004) have shown that periodontal ligament stem 
cells (PDLSCs) that are transplanted in nude mice, can form an ectopic cementum/ligament-like complex. 
Tissue regeneration mediated by human PDLSCs (Figure 3) represent a promising practical cell-based 
treatment for various periodontal diseases (Tamaki et al., 2013; Figure 3). In addition, a study from Meng’s 
laboratory (Zhang et al., 2014) has aimed to investigate human PDLSCs for their stem cell characteristics via 
analysis of cell surface marker expression, colony forming unit efficiency, osteogenic differentiation and 
adipogenic differentiation, and compared to BMSCs. This study has suggested that BMSCs owned the 
stronger immunomodulation in local microenvironment via anti-inflammatory functions, compared to 
PDLSCs (Zhang et al., 2014). In addition, Chen et al. (2015) has used the indirect co-culture approach to 
elucidate the effects of PDLSCs on differentiation of osteoblast-like cells and osteoclast precursors in 
culture, and found that PDLSCs promote osteoblastic differentiation of osteoblast precursors and osteoclastic 
differentiation of osteoclast precursors. 
 
Dental pulp stem cells (DPSCs) are derived from neural crest cells and represent one of the most widely 
used seed cells in the field bone tissue engineering/regeneration for several reasons, including their easily 
isolation, low immunogenicity, lack of ethical controversy and reduced rates of transplantation rejection 
(Pierdomenico et al., 2005; Huang et al., 2009; Sakai et al., 2012). DPSCs show MSC characteristics and can 
differentiate into many cell types, including odontoblasts, osteoblasts, chondrocytes. DPSCs are, therefore, 
capable of differentiation into bone cells, promoting both the regeneration and repair of alveolar bone defects 
(Huojia et al., 2015).   de Mendonca et al. (2008) have transplanted
 
human DPSC into large rat calvarial 
defects and found that they can differentiate into osteogenic cells without rejection of the graft. Moreover, 
dense collagen gel scaffolds seeded with rat DPSC (rDPSC) that were implanted in a rat critical-sized 
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calvarial defect model have accelerated both osteogenic DPSC differentiation and craniofacial bone 
regeneration (Chamieh et al., 2016). 
 
Other types of stem cells may also important in bone regeneration. A recent research by Szepesi et al. 
(Szepesi et al., 2016) has aimed to compare the properties of differentiated human MSCs from adult adipose 
tissue (AD-MSCs), Wharton's jelly of the umbilical cord (WJ-MSCs), and Periodontal ligament stem 
cells (PDLSCs) that were grown in culture. This study has also investigated the combined in vitro osteogenic 
and endothelial differentiation capacities of MSCs that were derived from Wharton's jelly, adipose tissue, 
and periodontal ligament, and found that MSCs that were isolated from periodontal ligament and adipose 
tissue are probably most appropriate for the generation vascularized bone graft Szepesi et al., 2016). Indeed, 
a recent experimental study in the dog has suggested adipose-derived stem cells as a tool for dental implant 
osseointegration (Bressan et al., 2015). Moreover, dental follicle (DF) stem cells have been shown to have a 
spontaneous tendency for osteogenic differentiation, and were suggested for bone regeneration (Lucaciu et 
al., 2015). 
 
Stem cell contributions to dentine regeneration and tooth engineering  
 
Tooth development results from sequential and reciprocal interactions between both the oral epithelium and 
the underlying neural crest-derived mesenchyme. The manipulation of stem cells is important for the 
generation of dental structures in the laboratory. This dental structure generation requires better 
understanding of the synergy of molecular and cellular events and mechanisms that are involved in the 
formation of various tooth-specific hard tissues, dentin and enamel.  
 
Over the past decade, the dental field has benefited from recent findings in stem cell biology and 
tissue engineering that led to the elaboration of novel ideas and concepts for the regeneration of dental 
tissues or entire new teeth. Stem cell-based regenerative approaches are, therefore, extremely promising 
since they aim at the full restoration of lost or damaged tissues, ensuring thus their functionality. These 
therapeutic approaches are already applied with success in clinics for the regeneration of other organs and 
consist of manipulation of stem cells and their administration to patients. Stem cells have the potential to 
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self-renew and to give rise to a variety of cell types that ensure tissue repair and regeneration throughout life 
(Miran et al., 2016). 
 
Mammalian teeth contain mesenchymal stem cells (MSCs) that contribute to both tooth growth and repair, 
and are characterized by both their accessibility and clinical relevance that provide a valuable opportunity to 
test stem cell-based treatments for dental defects (Sharpe, 2016). These dental MSCs show similar features to 
bone marrow-derived MSCs in culture, such as expression of certain markers, and clonogenicity, as well as 
differentiation into cells that have the characteristics of chondrocytes, osteoblasts and adipocytes. Teeth and 
their support tissues provide both easily accessible source of MSCs and a tractable model system to 
investigate them in vivo properties and function. (Sharpe, 2016).  Different types of MSCs have been 
extensively investigated for their capacity to form dentin in culture. In contrast, more studies are still needed 
for understanding the applications of epithelial stem cells in tooth regeneration, particularly because 
odontogenic potential resides in the oral epithelium and, therefore, epithelial stem cells are critical for tooth 
formation and production of enamel matrix. 
 
Tooth regeneration through stem cell-based therapy is a promising treatment for tooth decay and loss. 
Human dental pulp stem cells (hDPSCs) have been widely identified as the stem cells with the most potential 
for tooth tissue regeneration. However, growing culture of hDPSCs in culture for tissue engineering is still a 
challenge because cells may differentiate poorly and/or proliferate slowly in vivo. Dynamic 
three-dimensional (3D) simulated microgravity (SMG) created using the rotary cell culture system is 
considered to an effective tool, which contributes to several cell functions. A recent study by Li et al. (2017) 
has used various histological and immunohistochemical examinations of Ki-67, dentin sialoprotein, type I 
collagen and DMP-1, and found that both the proliferation and odontogenic differentiation abilities of the 
hDPSCs that were prepared in the 3D SMG culture system were higher, compared with those prepared in the 
static culture system. These results suggested that dynamic 3D SMG abilities of hDPSCs in vivo (Li et al., 
2017). 
 
Stem cell therapy is currently considered as a potential strategy to regenerate the dentin-pulp complex, 
enabling the conservation and restoration of functional teeth, and both standardization and establishment of 
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regulatory guidelines for stem cell therapy in clinical endodontics are a subject of intensive research. One of 
the key factors that induces subsets of dental pulp stem cells to form mobilized dental pulp stem cells 
(MDPSCs) is granulocyte-colony stimulating factor (G-CSF). It is well-established that good manufacturing 
practice is a prerequisite for both isolation and expansion of MDPSCs, which are enriched in stem cells that 
extensively express trophic factors with properties of high migration, proliferation, and antiapoptotic effects 
and endowed with regenerative potential. Nakashima and co-workers (2014) have found that autologous 
transplantation of MDPSCs with G-CSF in pulpectomized teeth in dogs augmented the regeneration of pulp 
tissue.  In this research, the quality of clinical-grade MDPSCs was confirmed by the absence of karyotypic 
abnormalities and the lack of tumor formation after transplantation in immune-deficient mice. This study has 
confirmed the combinatorial trophic effects of MDPSCs and G-CSF on cell migration, immunosuppression, 
anti-apoptosis, and neurite outgrowth were in culture, as well as has established the preclinical safety, 
feasibility, and efficacy of pulp regeneration by MDPSCs and G-CSF (Nakashima et al., 2014).  
 
Most recently, Qi et al. (2017) have demonstrated that the proliferation of hDPSCs was stimulated   after 
delta-like homologue (DLK1) overexpression, which suppressed the odontoblastic differentiation of 
hDPSCs, probably through ERK signaling pathway. Both DLK1 and p-ERK1/2 were strongly expressed on 
the odontoblasts and dental pulp cells on the first maxillary molar, and  
DLK1 expression levels increased after the odontoblastic induction of hDPSCs (Qi et al., 2017).  
Dental pulp stem cells also play an important role in pulp revascularization. The pulp vascular system 
actively contributes to waste removal, nutrient supply, and both pulp inflammatory response and 
subsequent regeneration. Under hypoxic stress, dental pulp cells release proangiogenic factors such as 
vascular endothelial growth factor. Exogenous vascular endothelial growth factor has widely applied   in 
tissue engineering (reviewed in Rombouts et al., 2017). It has been demonstrated that dental pulp stem 
cell secretome possesses angiogenic potential, which can contribute to the angiogenic process in different 
ways such as differentiating themselves into the endothelial lineage and guiding endothelial cells (Rombouts 
et al., 2017). 
 
Progenitor stem cell niches also exist in the post-natal pulp, and have important functions in both dentine 
formation and wound healing. Progenitor stem cell niches have a multi-potentiality property and, therefore, 
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can differentiate osteoblasts and chondrocytes in response to specific stimuli (Sloan and Waddington, 2009). 
They can also differentiate into odontoblasts and, therefore, are considered as a natural reparative 
mechanism. This can be triggered by an inflammation, injury or trauma that also affects their proliferation 
activities. For instance, inflammations in the dental regions have been found to associate with recruitment of 
tooth progenitor cells that migrate to the injury regions from their niches to stimulate the repairing 
mechanisms (Téclès et al., 2005).  In addition, (Løvschall et al. (2005) have investigated stem cell niches in 
vivo by Notch expression increment followed by pulpal injury. These experiments added further niches to 
the perivascular ones (Løvschall et al., 2005). 
 
Dental pulp stem cells and age-related changes 
Aging is the progressive decline of physiological integrity that leads to age-related degenerative diseases. 
Dental pulp has several functions, including pulp cell activity involvement in dentin formation.  Several 
changes have been reported during the aging process, including a progressive reduction of the pulpal 
chamber size, a progressive deposition of calcified masses in the root and coronal pulp, and fewer nerves, 
cells and blood vessels within the pulp, as well as an increase in the fibrous component (Pashley et al., 1994).  
In addition, both pulpal wound healing and cell regeneration are probably compromised with increasing age 
because of a sever reduction of potential stem/progenitor cell number in the dental pulp (Smith et al., 2005). 
 
The causes of dental pulp aging are unclear. It is still not clear whether age-related changes are due to 
intrinsic factors that exit during cell aging or are induced through extrinsic factors of the somatic 
environment (Sethe et al., 2006). Development of aging-related molecules in pulp cells requires better 
understanding of cellular and molecular mechanisms that are responsible for tooth preservation and 
maintenance strategies. 
 
 Lee et al. (2013) have investigated human dental pulp cells (hDPCs), and found that replicative senescence, 
which is often thought to be synonymous with aging, of these cells was characterized by both senescence-
associated β-galactosidase activity and reactive oxygen species formation. This study has further shown that 
hDPCs exhibited altered expression of several chronic inflammatory molecules, including peroxisome 
proliferator activated receptor-gamma, vascular cell adhesion molecule-1, intracellular adhesion molecule-1, 
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and heme oxygenase-1 and age-related molecules such as p53, p21, phosphorylated-extracellular signal-
regulated kinase, and c-myb. Furthermore, hDPCs decreased odontogenic markers such as dentin matrix-1 
and osteogenic markers such as bone morphogenetic protein-2 and -7, runt-related transcription factor-2, 
osteopontin, alkaline phosphatase activity, and mineralized nodule formation by replicative senescence (Lee 
et al., 2013).  
 
Human DPSCs (hDPSCs) are characterized by their rejuvenated capacity that relies on its resident stem cells. 
Until most recently, identification of the underlying molecular mechanisms that control dental pulp stem 
cells senescence and aging was hindered, mostly because of the lack of proper senescence models. Zhai and 
his colleagues (Zhai et al., 2017) have recently identified these age-related phenotypic changes by 
augmented senescence-associated-β-galactosidase (SA-β-gal) staining, elevated G0/G1 cell cycle arrest, 
increased apoptosis, and declined proliferation and differentiation capacity, as well as reactive oxygen 
species levels.  This study has also shown that dental pulp stem cells from young donors are more resistant to 
apoptosis and exhibit increased non-homologous end joining activity compared to old donors. They have 
also shown that induced dental pulp stem cells ageing is dependent on several factors and pathways such as 
genes associated with DNA damage and repair, mitochondrial dysfunction and increased reactive oxygen 
species levels (Zhai et al., 2017).  
 
Another type of stem cells, mesenchymal stem cells derived from human dental pulp (DP-MSCs), are 
characterized by self-renewal and multi-lineage differentiation and play important functional roles in 
regenerative medicine. The safest approach in cellular transplantations is autologous transfer, as non-
immunogenic. However, the applications of this autologous transfer in regenerative medicine may be limited 
by age-related changes (Feng et al., 2014). Indeed, several studies have reported a decrease in the osteogenic 
differentiation potential of MSC and an increase of MSC adipogenic potential with age, which has been 
coined as the adipogenic switch (D'Ippolito et al., 1999; Bergman et al., 1996; Ross et al., 2000; Stolzing et 
al., 2008). 
 
The age-related changes also influence mesenchymal stem cells (MSCs). The regenerative abilities of MSCs 
show an age-associated decline, probably due to several age-related changes in MSC number, intrinsic 
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properties of MSCs and extrinsic factors of the extracellular environment (the stem cell niche). Until 
recently, variable methods of MSC isolation and variations in stem cell populations have hindered 
investigations of the effect of age on the efficacy of MSC transplantation on regeneration. However, a study 
by Iohara et al. (2014) has provided a better understanding of the mechanisms involved in the age-dependent 
decline in pulp regeneration that are attributed to a decrease in the regenerative potential of resident stem 
cells. This study has demonstrated that MDPSCs from aged dogs were efficiently enriched in stem cells, 
expressing trophic factors with high migration, proliferation, and anti-apoptotic effects as in MDPSCs from 
young dogs. This research has, however, shown that pulp regeneration was retarded 120 days after 
autologous transplantation of aged MDPSCs. In addition, they have found that isolated periodontal 
ligament stem cells (PDLSCs) from aged dogs, which are representative of migrating stem cells from outside 
of the tooth compartment to regenerate pulp tissue, show lower migration, proliferation and anti-apoptotic 
abilities (Iohara et al., 2014).  
Conclusions and future directions 
In conclusion, this review has shown that different stem cell types, including human MSCs, and hAMSCs 
can differentiate into bone cells. Identification and isolation of these stem cell types and osteoprogenitor cells 
that are capable of osteochondral differentiation to inform both bone repair and regeneration are a subject of 
intensive recent studies that have been summarized in this review. The significant contributions of these 
various stem cell types in bone repair and regeneration, bone defects and both restoration and regeneration of 
bones and cartilages as well as dentine regeneration and tooth engineering were also discussed in the current 
review. The strategy of stem cell regeneration will probably provide new clinical solutions and interventions 
for various types of bone and tooth defects/disorders. However, to apply this new strategy, further studies are 
still required to fully understand stem cell behavior, and regulatory mechanisms and machineries, as well as 
stem cell functions and mechanisms in the treatment of various types of bone/tooth defects or disorders. 
Understanding these functions and mechanisms may help to identify novel targets for the prevention and 
rescue therapy of fatal bone disease in infancy and childhood and for bone regeneration after injury. In 
addition, future studies on the identification of molecular programs that control osteogenic differentiation of 
stem cells will be crucial for developing techniques that harness the ability of these cells to regenerate 
diseased and damaged bones and teeth. 
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Currently, there are many potential clinical studies that focus on the engineering of the entire tooth. 
However, the engineering of the entire tooth currently face several major challenges, including the ability to 
control tooth shape and size.  Furthermore, the conversion of the current research approaches of stem cells 
identification and characterization within the dental regions into applied clinical strategies is still also a 
major challenge. Further studies are needed for the development of these novel approaches because they can 
not be easily applied clinically for various reasons such the complexity of regeneration protocols for the 
injured pulp. Further studies are also needed to evaluate the applications of dental progenitor stem cells and 
to determine whether this stem cell approach can be successfully translated into clinic. 
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Figure Legends 
Figure 1. Intercellular communication pathways within the Basic Multicellular Unit (BMU) that 
comprise the remodeling process in trabecular bone. (1) Stimulatory and inhibitory signals from 
osteocytes to osteoblasts (e.g. OSM, PTHrP and sclerostin). (2) Stimulatory and inhibitory signals from 
osteoclasts to osteoblasts (e.g. matrix-derived TGFβ and IGF-1, secreted CT-1, Sema4D and S1P). (3) 
Signaling within the osteoblast lineage (e.g. ephrinB2 and EphB4, Sema3a, PTHrP, OSM). (4) Stimulatory 
and inhibitory signals between the osteoblast and osteoclast lineages (e.g. RANKL, Sema3B, Wnt5a and 
OPG). (5) Marrow cell signals to osteoblasts (e.g. macrophage-derived OSM, T-cell-derived interleukins and 
RANKL). Hemopoietic precursors (HSC), bone mesenchymal stem cells (MSCs). 
 
Figure 2. Stem cells for bone regeneration. Bone marrow stromal stem cells grown in a suitable 
extracellular medium can create a bone tissue structure. Thus, bone marrow stem cells can be grown in vitro, 
and cultured bone marrow osteoprogenitors can be used for regeneration of bone after seeding on an 
appropriate scaffold material. 
 
Figure 3. Periodontal Ligament (PDLSC) is a source of adult stem cells that can be used for stem cell-
delivery therapeutics for periodontal tissue regeneration. Mesenchymal stem cells are founded in dental 
tissues, including periodontal ligament, dental pulp, and dental papilla. They can be isolated and grown 
under defined tissue culture conditions, and used in tissue engineering, including, dental tissue, nerves and 
bone regeneration. Delivery of periodontal ligament stem cells (PDLSCs) to periodontal intra-bony defects 
via periodontal ligament cell sheet transplantation is shown in this Figure. In this cell sheet method, human 
periodontal ligament cells are isolated from an extracted tooth (1) and cultured on temperature-responsive 
culture dishes at 37°C (2). Transplantable cell sheets are harvested by reducing temperature to 20°C (3), and 
grafted onto an athymic rat periodontitis model 24 (4).  
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